In vivo activity and hydrophobicity of cytostatic aziridinyl quinones

Journal of Medicinal Chemistry

Volumn 39, Issue 3, 1996, Pages 720-728

  Moret, Ed E ^a   De Boer, Mark ^a   Hilbers, Hans W ^a   Tollenaere, Jan P ^a   Janssen, Lambert H M ^a   Holthuis, Joost J M ^a   Driebergen, Reinoud J ^a   Verboom, Willem ^b   Reinhoudt, David N ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZIRIDINYLBENZOQUINONE DERIVATIVE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLONOGENESIS; CYTOTOXICITY; HYDROGEN BOND; HYDROPHOBICITY; HYPOTHESIS; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PREDICTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOQUINONES; LEUKEMIA L1210; MELANOMA, EXPERIMENTAL; MICE;

EID: 0030032630     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9405147     Document Type: Article

References (64)

1. Wheeler, G. P. Studies Related to the Mechanisms of Action of Cytotoxic Alkylating Agents. A Review. Cancer Res. 1962, 22, 651-688.
2. Khan, A. H.; Driscoll, J. S. Potential Central Nervous System Antitumor Agents. Aziridinylbenzoquinones. 1. J. Med. Chem. 1976, 19, 313-317.
3. Chou, F.; Khan, A. H.; Driscoll, J. S. Potential Central Nervous System Antitumor Agents. Aziridinylbenzoquinones. 2. J. Med. Chem. 1976, 19, 1302-1308.
4. Driebergen, R. J.; Moret, E. E.; Janssen, L. H. M.; Blauw, J. S.; Beijnen, J. H.; Holthuis, J. J. M.; Postma Kelder, S. J.; Verboom, W.; Reinhoudt, D. N., Lelieveld, P. Electrochemistry of Potentially Bioreductive Alkylating Quinones. Part 4. Qualitative and Quantitative Structure-Activity Relationships of Aziridinylquinones. Recl. Trav. Chim. Pays-Bas 1993, 112, 174-185.
5. Lusthof, K. J.; De Mol, N. J.; Janssen, L. H. M.; Verboom, W.; Reinhoudt, D. N. DNA Alkylation and Formation of DNA Interstrand Cross-links by Potential Antitumour 2,5-Bis(1-Aziridinyl)-1,4-Benzoquinones. Chem.-Biol. Interact. 1989, 70, 249-262.
6. Lusthof, K. J.; De Mol, N. J.; Janssen, L. H. M.; Egberink, R. J. M.; Verboom, W.; Reinhoudt, D. N. Covalent Binding Studies on the 14C-Labeled Antitumour Compound 2,5-Bis(1-aziridinyl)-1,4-benzoquinone. Involvement of Semiquinone Radical in Binding to Proteins and Bacterial Macromolecules in situ. Chem.-Biol. Interact. 1990, 76, 193-209.
7. Butler, J.; Hoey, B. M.; Ward, T. H. The Alkylation of DNA in vitro by 2,5-Bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ) - I. Biochem, Pharmacol. 1989, 38, 923-927.
8. Hartley, J. A.; Berardini, M.; Ponti, M.; Gibson, N. W.; Thompson, A. S.; Thurston, D. E.; Hoey, B. M.; Butler, J. DNA Cross-Linking and Sequence Selectivity of Aziridinylbenzoquinones - A Unique Reaction at 5′-GC-3′ Sequences with 2,5-Diaziridinyl-1,4-Benzoquinone upon Reduction. Biochemistry 1991, 30, 11719-11724.
9. Lee, C. S.; Hartley, J. A., Berardini, M. D.; Butler, J.; Siegel, D.; Ross, D.; Gibson, N. W. Alternation in DNA Cross-Linking and Sequence Selectivity of a Series of Aziridinylbenzoquinones After Enzymatic Reduction by DT-Diaphorase. Biochemistry 1992, 31, 3019-3025.
10. Berardini, M. D.; Souhami, R. L.; Lee, C. S.; Gibson, N. W.; Butler, J.; Hartley, J. A. 2 Structurally Related Diaziridinylbenzoquinones Preferentially Cross-Link DNA at Different Sites upon Reduction with DT-Diaphorase. Biochemistry 1993, 32, 3306-3312.
11. Gutierrez, P. L.; Biswal, S.; Nardino, R.; Biswal, N. Reductive Activation of Diaziquinone and Possible Involvement of Free Radicals and the Hydroquinone Dianion. Cancer Res. 1986, 46, 5779-5785.
12. Gutierrez, P. L.; Nayar, M. S. B.; Nardino, R.; Callery, P. S. The Chemical Reduction of Diaziquinone: Products and Free Radical Intermediates. Chem.-Biol. Interact. 1987, 64, 23-377.
13. Gutierrez, P. L. Mechanism(s) of Bioreductive Activation. The Example of Diaziquinone (AZQ). Free Radical Med. 1989, 6, 405-445.
14. Prins, B.; Koster, A. S.; Verboom, W.; Reinhoudt, D. N. Microsomal Superoxide Anion Production and NADPH-Oxidation in a Series of 22 Aziridinylbenzoquinones. Biochem. Pharmacol. 1989, 38, 3753-3757.
15. Lusthof, K. J.; Richter, W.; De Mol, N.; Janssen, L. H. M.; Verboom, W.; Reinhoudt, D. N. Reductive Activation of Potential Antitumor Bis(aziridinyl)benzoquinones by Xanthine Oxidase: Competition between Oxygen Reduction and Quinone Reduction. Arch. Biochem. Biophys. 1990, 277, 137-142.
16. Lusthof, K. J.; De Mol, N. J.; Richter, W.; Janssen, L. H. M.; Butler, J.; Hoey, B. M.; Verboom, W.; Reinhoudt, D. N. Redox Cycling of Potential Antitumour Aziridinyl Quinones. Free Radical Biol. Med. 1992, 13, 599-608.
17. Butler, J.; Hoey, B. M. Are Reduced Quinones Necessarily involved in the Antitumour Activity of Quinone Drugs? Br. J. Cancer 1987, 55, Suppl. VIII, 53-59.
18. Lea, J. S.; Garner, H. J.; Butler, J.; Hoey, B. M.; Ward, T. H. The Lack of Correlation between Toxicity and Free Radical Formation of two Diaziridinyl Benzoquinones. Biochem. Pharmacol. 1988, 37, 2023-2025.
19. Butler, J.; Dzielendziak, A.; Lea, J. S.; Ward, T. H.; Hoey, B. M. Contrasting Cytotoxic Mechanisms of Similar Antitumor Diaziridinylbenzoquinones. Free Radical Res. Commun. 1990, 8, 231-239.
20. Lusthof, K. J.; De Mol, N. J.; Janssen, L. H. M.; Prins, B.; Verboom, W.; Reinhoudt, D. N. Interaction Between Potential Anti-Tumour BABQ Derivatives and Glutathione: Reductive Activation, Conjugation and DNA Damage. Anti-Cancer Drug Des. 1990, 5, 283-290.
21. Butler, J.; Hoey, B. M. Reactions of Glutathione and Glutathione Radicals with Benzoquinones. Free Radical Biol. Med. 1992, 12, 337-345.
22. Lin, A. J.; Cosby, L. A.; Shanksky, C. W.; Sartorelli, A. C. Potential Bioreductive Alkylating Agents. 1. Benzoquinone Derivatives. J. Med. Chem. 1972, 15, 1247-1252.
23. Gibson, N. W.; Hartley, J. A.; Butler, J.; Siegel, D.; Ross, D. Relationship between DT-Diaphorase-mediated Metabolism of a Series of Aziridinylbenzoquinones and DNA Damage and Cytotoxicity. Mol. Pharmacol. 1992, 42, 531-536.
24. Riley, R. J.; Workman, P. DT-Diaphorase and Cancer Chemotherapy. Biochem. Pharmacol. 1992, 43, 1657-1669.
25. Kirkpatrick, D. L. The Development of Hypoxic Tumor Cell Cytotoxic Agents. Pharmacol. Ther. 1989, 40, 383-399.
26. Tannock, I. F.; Rotin, D. Acid pH in Tumors and Its Potential for Therapeutic Exploitation. Cancer Res. 1989, 49, 4373-4384.
27. Vaupel, P.; Kallinowski, F.; Okunieff, P. Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review. Cancer Res. 1989, 49, 6449-6465.
28. Griffiths, J. R. Are Cancer Cells Acidic? Br. J. Cancer 1991, 64, 425-427.
29. Fujita, T.; Iwasa, J.; Hansch, C. A New Substituent Constant, π, derived from Partition Coefficients. J. Am. Chem. Soc. 1964, 86, 5175-5180.
30. Dearden, J. C. Partitioning and Lipophilicity in Quantitative Structure-Activity Relationships. Environ. Health Perspect. 1985, 61, 203-228.
31. Braumann, T. Determination of Hydrophobic Parameters by RPLC: Theory, Experimental Techniques, and Application in Studies on QSARs. J. Chromatogr. 1986, 373, 191-225.
32. Fujita, T.; Nishioka, T.; Nakajima, M. Hydrogen-Bonding Parameter and its Significance in Quantitative Structure-Activity Studies. J. Med. Chem. 1977, 20, 1071-1081.
33. Collander, R. The Partition of Organic Compounds Between Higher Alcohols and Water. Acta Chem. Scand. 1951, 5, 774-780.
34. Yoshimoto, M.; Miyazawa, H.; Nakao, H.; Shinkai, K.; Arakawa, M. Quantitative Structure-Activity Relationships in 2,5-Bis(1-aziridinyl)-p-benzoquinone Derivatives against Leukemia L-1210. J. Med. Chem. 1979, 22, 491-496.
35. Parodi, S.; Taningher, M.; Boero, P.; Santi, L. Quantitative Correlations amongst Alkaline DNA Fragmentation, DNA Covalent Binding, Mutagenicity in the Ames Test and Carcinogenicity, for 21 Compounds. Mutat. Res. 1982, 93, 1-24.
36. Kuramochi, H.; Motegi, A.; Maruyama, S.; Okamoto, K.; Takahashi, K.; Kogawa, O.; Notawari, H.; Hayami, H. Factor Analysis of in Vitro Antitumor Activities of Platinum Complexes. Chem. Pharm. Bull. 1990, 38, 123-127.
37. Mazerska, Z.; Mazerski, J.; Ledochowski, A. QSAR of Acridines. II. Features of Nitracrine Analogs for High Anti-Tumor Activity and Selectivity on Mice, searched by PCA and MRA Methods. Anti-Cancer Drugs Des. 1990, 5, 169-187.
38. Kowalski, B. R.; Bender, C. F. Pattern Recognition. A Powerful Approach to Interpreting Chemical Data. J. Am. Chem. Soc. 1972, 94, 5632-5639.
39. Malmowski, E. R. Abstract Factor Analysis - A Theory of Error and Its Application to Analytical Chemistry. In Chemometrics: Theory and Application, ACS Symposium Series 52; Kowalski, B. R., Ed.; American Chemical Society: Washington, D.C., 1977; pp 53-72.
40. Massart, D. L., Vandeginste, B. G. M., Deming, S. N., Michotte, Y., Kaufman, L., Eds.; Chemometrics: A Textbook; Data Handling in Science and Technology, Vol. 2.; Elsevier: Amsterdam, 1988.
41. Dunn, W. J. III; Wold, S.; Edlund, U.; Hellberg, S.; Gasteiger, J. Multivariate Structure-Activity Relationships Betwee Data from a Battery of Biological Tests and an Ensemble of Structure Descriptors: The PLS Method. Quant. Struct.-Act. Relat. 1984, 3, 131-137.
42. Cruciani, G.; Baroni, M.; Bonelli, D.; Clementi, S.; Ebert, C.; Skagerberg, B. Comparison of Chemometric Models for QSAR. Quant. Struct.-Act. Relat. 1990, 9, 101-107.
43. Cramer, R. D. III; Bunce, J. D.; Patterson, D. E. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quant. Struct.-Act. Relat. 1988, 7, 18-25.
44. Terada, H. Determination of log Poct by HPLC, and its Application in the Study of QSARs. Quant. Struct.-Act. Relat. 1986, 5, 81-88.
45. Recanatini, M. Hydrophobic Properties of Chromones and Flavones. Relationships between Octanol/Water Partition Coefficients and RP-HPLC Capacity Factors. Quant. Struct.-Act. Relat. 1987, 6, 12-17.
46. Yamagami, C.; Takami, H.; Yamamoto, K.; Miyoshi, K.; Takao, N. Hydrophobic Properties of Anticonvulsant Phenylacetanilides. Relation between Octanol/Water Partition Coefficient and Capacity Factor determined by RPLC. Chem. Pharm. Bull. 1984, 32, 4994-5002.
47. Betteridge, R. F.; Bosanquet, A. G.; Gilby, E. D. Pharmacokinetics of 2,5-Diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ, NSC224070) During a Phase I Clinical Trial. Eur. J. Cancer 1990, 26, 107-112.
48. Hansch, C.; Leo, A. Substituent Constants for Correlation Analysis in Chemistry and Biology; Wiley: New York, 1979.
49. Huntington, J. L.; Davis, D. G. EPR Studies of Amino and Other Quinones. J. Magn. Reson. 1970, 3, 456-467.
50. De Boer, M.; Moret, E. E.; Janssen, L. H. M.; Holthuis, J. J. M.; Driebergen, R. J.; Reinhoudt, D. N. Verboom, W. Lipophilicity of a Series of Cytostatic Aziridinyl Quinones. In QSAR: Quantitative Structure-Activity Relationships in Drug Design; Progress in Clinical and Biological Research Vol. 291; Fauchere, J. L., Ed.; Alan R. Liss Inc.: New York, 1989; pp 87-90.
51. Fujita, T. Analysis and Prediction of Partition Coefficients of meta- and para-Disubstituted Benzenes in Terms of Substituent Effects. J. Pharm. Sci. 1983, 72, 285-289.
52. Rich, P. R.; Harper, R. Partition Coefficients of Quinones and Hydroquinones and their Relation to Biochemical Reactivity. FEBS Lett. 1990, 139-144.
53. Huang, J. X.; Bouvier, E. S. P.; Stuart, J. D.; Melander, W. R.; Horvath, C. HPLC of Substituted p-Benzoquinones and p-Hydroquinones. II. Retention behavior, QSARs and Octanol-Water Partition Coefficients. J. Chromatogr. 1985, 330, 181-192.
54. Moret, E. E.; Janssen, L. H. M. Principal Component Analysis of the Cytostatic Activity of 2,5-(Bisaziridinyl)-1,4-Benzoquinones. In QSAR: Rational Approaches to the Design of Bioactive Compounds; Pharmacochemistry Library Vol. 16; Silippo, C., Vittoria, A., Eds.; Elsevier: Amsterdam, 1991; pp 381-384.
55. Lusthof, K. J.; Groothuis-Pielage, I. L.; Decuyper, J.; De Mol, N. J.; Janssen, L. H. M.; Verboom, W.; Reinhoudt, D. N. Potential Antitumor 2,5-bis(1-aziridinyl)-1,4-benzoquinones: Relationship between Cytotoxicity against DNA-Repair Deficient E. Coli Inactivation of Bacteriophage M13mp19, and in Vitro and in Vivo Antitumor Activity. Anti-Cancer Drug Des. 1988, 3, 147-155.
56. Hansch, C. QSAR in Cancer Chemotherapy. Il Farmaco Ed. Sc. 1979, 34, 89-104.
57. Driebergen, R. J.; Moret, E. E.; Janssen, L. H. M.; Blauw, J. S.; Holthuis, J. J. M.; Postma Kelder, S. J.; Verboom, W.; Reinhoudt, D. N.; Van der Linden, W. E. Electrochemistry of Potentially Bioreductive Alkylating Quinones. Part 3. Quantitative Structure-Electrochemistry Relationships of Aziridinylquinones. Anal. Chim. Acta 1992, 257, 257-273.
58. Pomonis, J. G.; Severson, R. F.; Hermes, P. A.; Zaylskie, R. G.; Terranova, A. C. Analysis of Insect Chemosterilants. Action of Phosphate Buffers on Aziridine. Anal. Chem. 1971, 43, 1709-1712.
59. Prins, B. Acute Toxicity in Potential Antitumour Bis(Aziridinyl)-Benzoquinones. Ph.D. Thesis, Utrecht, 1991.
60. Van der Sluis, W. G.; Van Arkel, J.; Fischer, F. C.; Labadie, R. P. Thin-layer Chromatographic Assay of Photoactive Compounds (Furocoumarins) using the Fungus Penicillium Expansum as a Test organism. J. Chromatogr. 1981, 214, 349-359.
61. NCSS Version 5.01. Number Cruncher Statistical System. Hintze, J. L.; Kaysville, UT, 1987.
62. Sybyl 6.0. Tripos Associates Inc.: St. Louis, MO 63144, 1992.
63. Holmes, H. L. Structure-Activity Relationships for Some Conjugated Heteroenoid Compounds, Catechol Monoethers and Morphine Alkaloids; Defense Research Establishment: Suffield, 1975.
64. Powis, G.; Appel, P. L. Relationship of the Single-Electron Reduction Potential of Quinones to their Reduction by Flavoproteins. Biochem. Pharmacol. 1980, 29, 2567-2572.